Abstract
BACKGROUND:
Exacerbations of COPD are a major component of the socioeconomic burden related to COPD, and frequent exacerbations are associated with greater decline in health status. Tracheobronchial infections are involved in 50–70% of exacerbations, so influenza and pneumococcal vaccines are recommended for prevention. The aim of this study was to determine the level of knowledge among COPD patients about the vaccines, find the rate of patients inoculated with both influenza and pneumococcal vaccines, and assess the effectiveness of vaccination status.


METHODS:
Patients with COPD were recruited from the out-patient clinic of our hospital between September and October 2012. Subject demographic data such as age, gender, level of education, and smoking status were recorded. Vaccination status, number of subjects who were informed by a health-care professional about immunization, and COPD-related emergency or hospital admissions triggered by tracheobronchial infections over 1 y after administration of both influenza and pneumococcal vaccines were noted.


RESULTS:

Eighty-eight subjects were enrolled during the study period. Eighty-two subjects were male (93.2%), 6 subjects were female (6.8%), and the median age was 61.5 y. According to Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2006 classification, 5 subjects were in stage 1 (5.7%), 22 subjects were in stage 2 (25%), 34 subjects were in stage 3 (38.6%), and 27 subjects were in stage 4 (30.7%). Sixty-two subjects had graduated from primary school (70.5%), 21 subjects had graduated from high school (23.9%), one subject had graduated from university (1.1%), and 4 subjects had no education (4.5%). Forty-five subjects (51%) were vaccinated. There was no significant correlation between level of education and vaccination status (
P
= .37). Both COPD-related emergency department and hospital visits were significantly decreased in vaccinated patients with COPD (
P
< .001 and
P
= .02, respectively). Of all the subjects, 39.7% (35 of 88 subjects) mentioned that no health-care professional recommended vaccination.



CONCLUSIONS:
Physicians should be more aware of vaccination and recommend both influenza and pneumococcal vaccines to all patients with COPD to reduce exacerbations.
Topics

No keywords indexed for this article. Browse by subject →

References
27
[1]
Global Initiative for Chronic Obstructive Lung Disease (GOLD 2011). Global strategy for the diagnosis management and prevention of COPD. http://www.goldcopd.org/Guidelines/guidelines-resources.html. Accessed August 22 2013.
[16]
Poole PJ, , Chacko E, , Wood-Baker RW, , Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2006;(1):CD002733.
[17]
Leech JA, , Gervais A, , Ruben FL. Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease. CMAJ, 1987; 136(4):361–365.
[20]
Centers for Disease Control and Prevention. Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Mortal Wkly Rep, 2002; 51:1–24.
[22]
Tasbakan MS, , Pullukcu H, , Sipahi H, , Tasbakan MI. [The evaluation of influenza vaccination rate and knowledge about influenza vaccination in patients with chronic obstructive pulmonary disease]. İnfeksiyon Dergisi, 2007; 21(2):89-92. Article in Turkish.
[23]
Department of Health and Human Services Centers for Disease Control and Prevention. National Immunization Program Advisory Committee on Immunization Practices June 29-30 2006 Atlanta GA. Record of the Proceedings. http://www.michigan.gov/documents/mdch/AcipMinJun06_FB100506_174608_7.pdf. Accessed September 17 2014.
[24]
Özol D, , Özçakar B. [The rate of influenza vaccination in patients with COPD]. Akciğer Arşivi, 2005; 6:133-136. Article in Turkish.
Related

You May Also Like

Clinical Pharmacology of Corticosteroids

Dennis M Williams · 2018

374 citations

Past and Present ARDS Mortality Rates: A Systematic Review

Jan Maca, Ondrej Jor · 2016

274 citations

Asthma and Adherence to Inhaled Corticosteroids: Current Status and Future Perspectives

Camilla Boslev Bårnes, Charlotte Suppli Ulrik · 2014

260 citations

Cystic Fibrosis Lung Disease: An Overview

Nelson L Turcios · 2019

187 citations